Empfehlungen für Sportler mit arterieller Hypertonie

Zusammenfassung

Aktuelle Richtlinien der Europäischen Gesellschaft für Kardiologie und anderen namhaften internationalen Fachgesellschaften geben regelmäßiger körperlicher Aktivität zur Vorbeugung und Behandlung von Herz-Kreislauf-Erkrankungen die höchste Evidenzklasse IA. Dies gilt auch für Sportler mit arterieller Hypertonie, wenngleich hier einige Besonderheiten zu beachten sind. Mit dem Ziel, Kollegen, die Sportler mit arterieller Hypertonie betreuen, eine evidenzbasierte Hilfestellung zu geben, wurden unter meiner Federführung in Zusammenarbeit mit Kollegen der Sektion Sportkardiologie der European Association of Preventive Cardiology der European Society of Cardiology diese Empfehlungen erstellt; sie können Open Access beim European Heart Journal heruntergeladen werden.

Abstract

Current guidelines of the European Society of Cardiology and other renowned international professional associations give regular physical activity for the prevention and treatment of cardiovascular disease the highest evidence class IA. This also applies to athletes with arterial hypertension, although there are some special features to be considered. With the aim of providing evidence-based support to colleagues who care for athletes with arterial hypertension, these recommendations were prepared under my leadership in collaboration with colleagues from the Sports Cardiology Section of the European Association of Preventive Cardiology of the European Society of Cardiology and can be downloaded open access from the European Heart Journal.

Schlüsselwörter

Sportler - Sporttauglichkeit - arterielle Hypertonie

Key words

arterial hypertension - athletes - atherosclerosis - cardiac events - target organ damage - pre-participation screening

• Literatur

• 1 Piepoli MF, Hoes AW, Agewall S. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2016; 37: 2315-2381
• 2 Niebauer J, Börjesson M, Carre F. et al. Recommendations for participation in competitive sports of athletes with arterial hypertension: a position statement from the sports cardiology section of the European Association of Preventive Cardiology (EAPC). Eur Heart J 2018; 39: 3664-3671
• 3 Rodriguez CJ, Sacco RL, Sciacca RR. et al. Physical activity attenuates the effect of increased left ventricular mass on the risk of ischemic stroke: The Northern Manhattan Stroke Study. J Am Coll Cardiol 2002; 39: 1482-1488
• 4 Mancia G, Fagard R, Narkiewicz K. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-2219
• 5 Laukkanen JA, Khan H, Kurl S. et al. Left ventricular mass and the risk of sudden cardiac death: a population-based study. J Am Heart Assoc 2014; 3: e001285
• 6 Laukkanen JA, Jennings JR, Kauhanen J. et al. Relation of systemic blood pressure to sudden cardiac death. Am J Cardiol 2012; 110: 378-382
• 7 Okin PM, Bang CN, Wachtell K. et al. Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy. Circ Arrhythm Electrophysiol 2013; 6: 243-251
• 8 Black HR, Sica D, Ferdinand K. et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology. Circulation 2015; 132: e298-e302
• 9 Selden MA, Helzberg JH, Waeckerle JF. Early cardiovascular mortality in professional football players: fact or fiction?. Am J Med 2009; 122: 811-814
• 10 Baron SL, Hein MJ, Lehman E. et al. Body mass index, playing position, race, and the cardiovascular mortality of retired professional football players. Am J Cardiol 2012; 109: 889-896
• 11 Hurst RT, Burke RF, Wissner E. et al. Incidence of subclinical atherosclerosis as a marker of cardiovascular risk in retired professional football players. Am J Cardiol 2010; 105: 1107-1111
• 12 Sundstrom J, Neovius M, Tynelius P. et al. Association of blood pressure in late adolescence with subsequent mortality: cohort study of Swedish male conscripts. BMJ 2011; 342: d643
• 13 Pelliccia A, Fagard R, Bjornstad HH. et al. Recommendations for competitive sports participation in athletes with cardiovascular disease. Eur Heart J 2005; 26: 1422-1445
• 14 Solberg EE, Borjesson M, Sharma S. et al. Sudden cardiac arrest in sports – need for uniform registration: A Position Paper from the Sport Cardiology Section of the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Prev Cardiol 2016; 23: 657-667
• 15 OʼBrien E, Parati G, Stergiou G. et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013; 31: 1731-1768
• 16 Parati G, Stergiou G, OʼBrien E. et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 2014; 32: 1359-1366
• 17 Jardim TV, de Souza Carneiro C, Morais P. et al. Home blood pressure normalcy in non-European adolescents. J Hypertens 2018; 36: 61-68
• 18 Le VV, Mitiku T, Sungar G. et al. The blood pressure response to dynamic exercise testing: a systematic review. Prog Cardiovasc Dis 2008; 51: 135-160
• 19 Schultz MG, La Gerche A, Sharman JE. Blood Pressure Response to Exercise and Cardiovascular Disease. Curr Hypertens Rep 2017; 19: 89
• 20 Caselli S, Vaquer Segui A, Quattrini F. et al. Upper normal values of blood pressure response to exercise in Olympic athletes. Am Heart J 2016; 177: 120-128
• 21 Kjeldsen SE, Mundal R, Sandvik L. et al. Supine and exercise systolic blood pressure predict cardiovascular death in middle-aged men. J Hypertens 2001; 19: 1343-1348
• 22 Mosconi G, Angelini ML, Balzi W. et al. Can Solid-Organ-Transplanted Patients Perform a Cycling Marathon? Trends in Kidney Function Parameters in Comparison With Healthy Subjects. Transplant Proc 2016; 48: 415-419
• 23 Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen?. Eur Heart J 2014; 35: 1245-1254
• 24 Leddy JJ, Izzo J. Hypertension in athletes. J Clin Hypertens (Greenwich) 2009; 11: 226-233
• 25 Achar S, Rostamian A, Narayan SM. Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm. Am J Cardiol 2010; 106: 893-901
• 26 Baggish AL, Weiner RB, Yared K. et al. Impact of family hypertension history on exercise-induced cardiac remodeling. Am J Cardiol 2009; 104: 101-106
• 27 Caselli S, Montesanti D, Autore C. et al. Patterns of left ventricular longitudinal strain and strain rate in Olympic athletes. J Am Soc Echocardiogr 2015; 28: 245-253
• 28 Caselli S, Di Paolo FM, Pisicchio C. et al. Patterns of left ventricular diastolic function in Olympic athletes. J Am Soc Echocardiogr 2015; 28: 236-244
• 29 Galderisi M, Lomoriello VS, Santoro A. et al. Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study. J Am Soc Echocardiogr 2010; 23: 1190-1198
• 30 World Anti-Doping Agency. Prohibited List. Im Internet: https://www.wada-ama.org/sites/default/files/prohibited_list_2018_en.pdf Stand: 15.02.2020
• 31 Pescatello LS, Franklin BA, Fagard R. et al. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 2004; 36: 533-553
• 32 ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-2997
• 33 James PA, Oparil S, Carter BL. et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507-520
• 34 Naci H, Ioannidis JP. Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. Br J Sports Med 2015; 49: 1414-1422
• 35 Howden EJ, Sarma S, Lawley JS. et al. Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial: Implications For Heart Failure Prevention. Circulation 2018; 137: 1549-1560 doi:10.1161/CIRCULATIONAHA.117.030617
• 36 Corrado D, Pelliccia A, Bjornstad HH. et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death. Eur Heart J 2005; 26: 516-524
• 37 Pelliccia A, Adami PE, Quattrini F. et al. Are Olympic athletes free from cardiovascular diseases? Systematic investigation in 2352 participants from Athens 2004 to Sochi 2014. Br J Sports Med 2017; 51: 238-243
• 38 Pelliccia A, Quattrini FM, Squeo MR. et al. Cardiovascular diseases in Paralympic athletes. Br J Sports Med 2016; 50: 1075-1080